Li, Y., Li, Y., Li, T., He, M., Chang, J., Cao, H., . . . Cheng, X. (2025). Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer. Frontiers in Oncology, 15, . https://doi.org/10.3389/fonc.2025.1527277
Chicago-referens (17:e uppl.)Li, Yongxia, et al. "Efficacy and Safety of Pyrotinib in the Treatment of HER2-positive Liver Metastatic Advanced Breast Cancer." Frontiers in Oncology 15 (2025). https://doi.org/10.3389/fonc.2025.1527277.
MLA-referens (9:e uppl.)Li, Yongxia, et al. "Efficacy and Safety of Pyrotinib in the Treatment of HER2-positive Liver Metastatic Advanced Breast Cancer." Frontiers in Oncology, vol. 15, 2025, https://doi.org/10.3389/fonc.2025.1527277.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
